Synthetic biology and QA/QC testing market for cannabinoids

Synthetic biology and QA/QC testing market for cannabinoids The passage is a commercial market analysis describing production methods and testing opportunities for CBD. It mentions no high‑profile officials, agencies, or controversial financial flows, and provides no actionable investigative leads. Key insights: Synthetic biology can produce cannabinoids via fermentation.; QA/QC testing standards for CBD are currently fragmented across states.; Life‑science instrument makers (Agilent, Danaher, PerkinElmer, Shimadzu, Thermo Fisher, Waters) could benefit.